By the Corex Vitality™ Research Team · Last checked 12 November 2026 · Sources listed under Published Research
Quick summary
- KPV is a tripeptide: a chain of just three amino acids, lysine (K), proline (P) and valine (V).
- It matches the last three building blocks of alpha-MSH, a natural 13-amino-acid signalling peptide.
- Cell studies have looked at how KPV gets into cells and how it relates to the NF-κB signalling switch.
- Analytical papers describe its shape, how it breaks down, and how to measure it by HPLC.
- How KPV works inside cells is still debated. Different labs point to different routes.
The KPV peptide is one of the smallest molecules in the research peptide literature. It has only three amino acids, yet it has been studied for more than 25 years in chemistry and cell biology labs. This guide explains where KPV comes from, what its structure looks like, and what published laboratory work has measured. If you are new to the subject, start with What Are Peptides?
1. What KPV is
- Sequence: Lys-Pro-Val, written KPV in one-letter code. An amino acid is a small building block; peptides are short chains of them.
- Size: a tripeptide, meaning three amino acids joined by peptide bonds.
- Formula: the free tripeptide is C16H30N4O4, with a molar mass of about 342.4 g/mol.
- CAS number: 67727-97-3, a unique registry number used to identify a chemical.
Some papers study a “capped” version, written Ac-KPV-NH2. The acetyl cap (Ac) on one end and the amide (NH2) on the other copy how the sequence sits at the end of its parent peptide. Always check which form a paper used before comparing results.
2. Where it comes from: alpha-MSH
Alpha-melanocyte-stimulating hormone (alpha-MSH) is a natural peptide of 13 amino acids. It acts on a family of five melanocortin receptors (MC1R to MC5R), which are proteins on the cell surface that recognise it and pass on a signal.
KPV is positions 11 to 13 of alpha-MSH, the very end of the chain. That end is called the C-terminus. Researchers became interested in it when earlier work suggested that this short end piece carried some of the parent peptide’s signalling activity on its own. Another short peptide with a similar story is Pinealon (EDR).
3. What its shape looks like
A 2001 study used molecular dynamics (computer simulation of how atoms move) to map the shapes the capped tripeptide can take. The authors grouped the shapes into families and used the lowest-energy ones as templates for six models of rigid, non-peptide look-alikes.
Proline matters here. Its ring structure limits how the chain can bend, so even a three-amino-acid peptide has a preferred set of shapes.
4. Getting into the cell: PepT1
A 2008 study tested human intestinal epithelial cell lines (cells that line the gut, grown in a dish) and a human T-cell line. The team looked at PepT1, a transporter protein that carries small two- and three-amino-acid peptides across the cell membrane.
- Radio-labelled KPV was taken up by the cells, and the uptake behaved like a PepT1 substrate.
- In cells stimulated with signalling proteins called cytokines, nanomolar KPV (billionths of a mole per litre) reduced activation of NF-κB and MAP kinase pathways.
- The same paper also included mouse experiments. Those are a separate type of study and are not summarised here.
NF-κB is a protein complex that acts like a switch. When a cell is stimulated, NF-κB moves into the nucleus (the cell’s control centre) and turns on genes for signalling molecules. MAP kinases are a chain of enzymes that relay signals inside the cell. Many cell studies use a reporter gene, a gene that makes a glowing protein when NF-κB is active, as a simple read-out.
5. The receptor question
Not every lab agrees on how KPV acts. A 2004 study in human skin-derived cells called keratinocytes found that neither alpha-MSH nor KPV raised cyclic AMP, a common messenger made after melanocortin receptors are switched on.
Under certain test conditions, both peptides did trigger rapid rises in calcium inside the cells. In hamster ovary cells engineered to carry MC1R, KPV also raised calcium. So one line of work points to transport into the cell, and another to a receptor at the surface. Both may be part of the picture, and the question is still open. For why cell results do not automatically carry over to whole organisms, see In Vitro vs In Vivo vs Ex Vivo.
6. Stability and measurement
A 2015 paper built a stability-indicating HPLC method for KPV. HPLC (high-performance liquid chromatography) separates the parts of a sample so each shows as a peak. “Stability-indicating” means the method can tell the intact peptide apart from its breakdown products.
- The method used a C18 column and a water/acetonitrile gradient containing 0.1% trifluoroacetic acid (TFA).
- Under acid, alkali and hydrogen peroxide stress, the main breakdown product was a Lys-Pro diketopiperazine: a small ring formed when the first two amino acids split off and close up.
A 2018 study modified the lysine in KPV with a sugar-derived group (“glycoalkylation”). The modified versions resisted digestion by protein-cutting enzymes. In that study’s bacterial assays, neither capped KPV nor the modified versions showed antimicrobial activity.
To read peaks like these, see our HPLC chromatogram guide, peptide impurities explained and TFA vs acetate counter-ions.
7. KPV at Corex Vitality™
KPV research peptide is listed in 5mg (£25.99) and 10mg (£32.99) lyophilised vials. It is currently on Limited availability, usually dispatched within 14 to 21 days. COA published when this batch arrives; you can then check it with our COA verification guide. A 10ml BAC Water bundle is £5.99 with any peptide, free on orders over £100. There is also a short KPV research video.
Key takeaways
- KPV is the Lys-Pro-Val tripeptide, the last three amino acids (11 to 13) of alpha-MSH.
- Cell studies link it to PepT1 transport and reduced NF-κB and MAP kinase activation in stimulated cells.
- Other cell work suggests a receptor-linked calcium signal. How it acts is not settled.
- Analytical papers give HPLC methods and identify a diketopiperazine as the main breakdown product.
- All of this is laboratory research. Corex Vitality™ supplies KPV for in-vitro research use only. Browse more articles, the Learning Hub and the research glossary.
Published Research
The peer-reviewed papers below were used for the science in this article. Each entry was checked against PubMed (NCBI E-utilities) on 12 November 2026. Summaries describe study design and laboratory methods only. Corex Vitality™ is not affiliated with the cited authors, journals or institutions.
- Conformational analysis of tripeptide Ac-Lys-Pro-Val-NH2, COOH-terminal sequence of alpha-MSH. Chavatte P, Yous S, Lesieur D, et al. J Pharm Pharmacol. 2001;53(7):949-53. PMID: 11480545 · DOI: 10.1211/0022357011776360
Computational study using molecular dynamics to map the possible shapes (conformations) of the capped tripeptide Ac-Lys-Pro-Val-NH2, the C-terminal sequence of alpha-MSH, and using the lowest-energy shapes as templates for constrained non-peptide analogue models. - PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. Gastroenterology. 2008;134(1):166-78. PMID: 18061177 · DOI: 10.1053/j.gastro.2007.10.026
Cell-based study in human intestinal epithelial cell lines (Caco2-BBE, HT29-Cl.19A) and Jurkat T cells measuring PepT1-dependent uptake of radio-labelled KPV and its effect on cytokine-stimulated NF-κB and MAP kinase signalling (reporter gene, Western blot, RT-PCR, ELISA); the paper also includes separate mouse experiments not summarised here. - alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. Elliott RJ, Szabo M, Wagner MJ, et al. J Invest Dermatol. 2004;122(4):1010-9. PMID: 15102092 · DOI: 10.1111/j.0022-202X.2004.22404.x
In-vitro signalling study in HaCaT and normal human keratinocytes and MC1R-transfected Chinese hamster ovary cells measuring cyclic AMP and intracellular calcium responses to alpha-MSH, KPV, KP-D-V and ACTH peptides. - Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Pawar KR, Mulabagal V, Smith F, et al. Biomed Chromatogr. 2015;29(5):716-21. PMID: 25298219 · DOI: 10.1002/bmc.3347
Analytical chemistry paper developing and validating a stability-indicating reversed-phase HPLC method for KPV, and identifying a Lys-Pro diketopiperazine as the main breakdown product under acid, alkali and peroxide stress. - Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue. Songok AC, Panta P, Doerrler WT, et al. PLoS One. 2018;13(6):e0199686. PMID: 29953505 · DOI: 10.1371/journal.pone.0199686
Synthetic chemistry study modifying the lysine residue of KPV by reductive glycoalkylation, characterising the products, and testing their stability to protein-cutting enzymes and their activity in bacterial assays.
All Corex Vitality™ products are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use. No information here describes use in humans or animals.

Free guide
How to read a COA
Get it by email, plus our research updates. No spam, unsubscribe any time.